Evidence map›Paper›PMID 26847692›Full record

ArticleNanoscale research letters2016

Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.

Valeria Márquez-Miranda, Juan Pablo Peñaloza, Ingrid Araya-Durán, Rodrigo Reyes, Soledad Vidaurre, Valentina Romero, Juan Fuentes, Francisco Céric, Luis Velásquez, Fernando D González-Nilo and 1 more

Abstract read
In one paragraph

Article in Nanoscale research letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Use of Polyamidoamine Dendrimers in Brain Diseases.Molecules (Basel, Switzerland) · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valeria Márquez-MirandaFacultad de Biología, Center for Bioinformatics and Integrative Biology (CBIB), Universidad Andres Bello, Republica 239, Santiago, Chile.
Juan Pablo PeñalozaFacultad de Medicina, Center for Integrative Medicine and Innovative Science, Universidad Andres Bello, Santiago, Chile.
Ingrid Araya-DuránFacultad de Biología, Center for Bioinformatics and Integrative Biology (CBIB), Universidad Andres Bello, Republica 239, Santiago, Chile.
Rodrigo ReyesFacultad de Medicina, Center for Integrative Medicine and Innovative Science, Universidad Andres Bello, Santiago, Chile.
Soledad VidaurreDepartamento Ciencias Químicas y Biológicas, Laboratorio de Bionanotecnología, Universidad Bernardo O'Higgins, Santiago, Chile.
Valentina RomeroDepartamento Ciencias Químicas y Biológicas, Laboratorio de Bionanotecnología, Universidad Bernardo O'Higgins, Santiago, Chile.
Juan FuentesFacultad de Biología, Laboratorio de Microbiología, Universidad Andres Bello, Republica 217, Santiago, Chile.
Francisco CéricLaboratorio de Neurociencias Cognitivas, Facultad de Psicología, Universidad del Desarrollo, Santiago, Chile.
Luis VelásquezFundación Fraunhofer Chile Research, M. Sánchez Fontecilla 310 piso 14, Las Condes, Chile.
Fernando D González-NiloFacultad de Biología, Center for Bioinformatics and Integrative Biology (CBIB), Universidad Andres Bello, Republica 239, Santiago, Chile. fernando.gonzalez@unab.cl.
Carolina OteroFundación Fraunhofer Chile Research, M. Sánchez Fontecilla 310 piso 14, Las Condes, Chile. maria.otero@unab.cl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(amidoamine) dendrimers are the most recognized class of dendrimer. Amino-terminated (PAMAM-NH2) and hydroxyl-terminated (PAMAM-OH) dendrimers of generation 4 are widely used, since they are commercially available. Both have different properties, mainly based on their different overall charges at physiological pH. Currently, an important function of dendrimers as carriers of short single-stranded DNA has been applied. These molecules, known as antisense oligonucleotides (asODNs), are able to inhibit the expression of a target mRNA. Whereas PAMAM-NH2 dendrimers have shown to be able to transfect plasmid DNA, PAMAM-OH dendrimers have not shown the same successful results. However, little is known about their interaction with shorter and more flexible molecules such as asODNs. Due to several initiatives, the use of these neutral dendrimers as a scaffold to introduce other functional groups has been proposed. Because of its low cytotoxicity, it is relevant to understand the molecular phenomena involving these types of dendrimers. In this work, we studied the behavior of an antisense oligonucleotide in presence of both types of dendrimers using molecular dynamics simulations, in order to elucidate if they are able to form stable complexes. In this manner, we demonstrated at atomic level that PAMAM-NH2, unlike PAMAM-OH, could form a well-compacted complex with asODN, albeit PAMAM-OH can also establish stable interactions with the oligonucleotide. The biological activity of asODN in complex with PAMAM-NH2 dendrimer was also shown. Finally, we revealed that in contact with PAMAM-OH, asODN remains outside the cells as TIRF microscopy results showed, due to its poor interaction with this dendrimer and cell membranes.

Identifiers

PMID26847692
PMCPMC4742457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.